BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12885448)

  • 1. A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.
    Phillips C; Guiney M; Smith J; Hughes P; Narayan K; Quong G
    Radiother Oncol; 2003 Jul; 68(1):23-6. PubMed ID: 12885448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elderly and poor prognosis patients with high grade glioma: hypofractionated radiotherapy.
    Donato V; Monaco A; Rollo A; Messineo D; Santuari L; Castrichino A; Caiazzo R; Salvati M; Delfini R; Banelli E
    Clin Ter; 2007; 158(3):227-30. PubMed ID: 17612282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of conventional radiotherapy in malignant gliomas:].
    Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
    Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of local radiotherapy and modified total-brain irradiation in astrocytoma].
    Fritz P; Becker F; Kuttig H; zum Winkel K
    Strahlenther Onkol; 1989 Aug; 165(8):571-7. PubMed ID: 2549649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for glioblastoma in the elderly.
    Keime-Guibert F; Chinot O; Taillandier L; Cartalat-Carel S; Frenay M; Kantor G; Guillamo JS; Jadaud E; Colin P; Bondiau PY; Meneï P; Loiseau H; Bernier V; Honnorat J; Barrié M; Mokhtari K; Mazeron JJ; Bissery A; Delattre JY;
    N Engl J Med; 2007 Apr; 356(15):1527-35. PubMed ID: 17429084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).
    Urtasun RC; Cosmatos D; DelRowe J; Kinsella TJ; Lester S; Wasserman T; Fulton DS
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):207-14. PubMed ID: 8407393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options in high-grade brain tumors: brain brachytherapy.
    Chin HW; Lefkowitz DM; Eisenberg RL
    Radiographics; 1992 Jul; 12(4):721-9. PubMed ID: 1321981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial irradiation for CNS lesions.
    Teixeira MJ; Lepski G; Correia C; Aguiar PH
    Stereotact Funct Neurosurg; 2003; 81(1-4):24-9. PubMed ID: 14742960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging.
    Seither RB; Jose B; Paris KJ; Lindberg RD; Spanos WJ
    Am J Clin Oncol; 1995 Aug; 18(4):297-9. PubMed ID: 7625369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture therapy. Clinical brain tumor studies.
    Nakagawa Y; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):105-15. PubMed ID: 9151228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience.
    Chun M; McKeough P; Wu A; Kasdon D; Heros D; Chang H
    Br J Radiol; 1989 Feb; 62(734):158-62. PubMed ID: 2538197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
    Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated conformal irradiation of patients with malignant glioma.
    Aboziada MA; Abo-Kresha AE
    J Egypt Natl Canc Inst; 2012 Sep; 24(3):139-43. PubMed ID: 22929920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.
    Brady LW; Miyamoto C; Woo DV; Rackover M; Emrich J; Bender H; Dadparvar S; Steplewski Z; Koprowski H; Black P
    Int J Radiat Oncol Biol Phys; 1992; 22(1):225-30. PubMed ID: 1309204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.